Iman Nahvi

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

Hälg & Co. AG provides building technology services and solutions in the areas of heating, ventilation, air conditioning, refrigeration, and sanitation. The company was founded by Ferdinand Hälg in 1922 and is headquartered in St. Gallen, Switzerland.

Xantos AG is a functional biology and drug discovery company developing biopharmaceuticals in the areas of cancer and metabolic diseases. Its business model is to develop drug discovery pipelines based on the validated targets and leads generated by its proprietary through target identification and validation system and to form indication specific joint research and development collaborations with pharmaceutical and biotechnology companies. It also offers customers its proprietary technology and cDNA/siRNA screening tools for research service deals. The company is headquartered in Munich, Germany.

JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.

Fortimo Group AG operates as a holding company, which engages in the acquisition, brokerage, development, and sale of residential real estate. It offers properties for sale such as condominiums, single-family houses, commercial buildings, and building land. The firm also subleases properties such as apartments, single-family houses, and commercial buildings. The company was founded by Philipp Bienz and Remo Bienz in 2000 and is headquartered in St. Gallen, Switzerland.

Tube Pharmaceuticals GmbH develops a new class of anti cancer drugs. Its products include Tubulysins and their synthetic analogs and next generation Epothilones. The company assets are natural product classes and their synthetic analogues comprising a product platform with multiple partnering and development opportunities. It focuses on synthetic substances for the cancer therapy, derived from natural substances. The company was founded in 2011 and is headquartered in Vienna, Austria.

Dacuda AG engages in the provision of image processing and scanning solutions. It specializes in the development of image scanning, processing, and computer vision solutions. The firm solution areas encompass image editing, content sharing, and data integration. It develops solutions for mobile phone, web cam, and digital camera applications. The company was founded by Fleisch Elgar, Erik Fonseka, Michael Born, Martin Zahnert, and Alexander Ilic in 2008 and is headquartered in Zurich, Switzerland.

EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA.

Proterris, Inc. manufactures applications of low-dose carbon monoxide. It develops carbon monoxide for delayed graft function in renal transplant recipients and idiopathic pulmonary fibrosis. The company was founded by Jeffrey Wager and Joseph Wager and is headquartered in Boston, MA.

Censhare AG develops online platform which pools all marketing and communications content within one information-centric system. The company is headquartered in Munich, Germany.

S2S Ventures AG (S2S) is an independent venture capital firm founded in 2021 by Thomas Meier, Cynthia Jurytko and Alexander Ilic. The firm is headquartered in Zurich.